Abstract #3121

Optimized CEST acquisition and analysis for treatment assessment of response to neoadjuvant chemotherapy in triple negative breast cancer

Shu Zhang¹, Abeer H. Abdelhafez², Jong Bum Son³, Benjamin C. Musall³, Mitsuharu Miyoshi⁴, Xinzeng Wang⁵, Ken-Pin Hwang³, Gaiane M. Rauch², Jingfei Ma³, and Mark D. Pagel¹

¹Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, United States, ²Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, United States, ³Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States, ⁴Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan, ⁵Global MR Applications & Workflow, GE Healthcare, Houston, TX, United States

In our ongoing study of 13 completed patients, we compared two saturation power levels (2.0 μT vs. 0.9 μT) and two analysis methods (MTR_asym vs. Lorentzian line fitting) of CEST for assessing treatment response to neoadjuvant chemotherapy of triple-negative breast cancer (TNBC). A consistently decreasing trend of the CEST signals was observed with the longitudinal treatment when a higher saturation power of 2.0 μT was used with the amide MTR_asym analysis method. In contrast, the same trend was observed when a lower saturation power of 0.9 μT was used for the Lorentzian line fitting analysis method.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.